Serum metabolites in non-alcoholic fatty-liver disease development or reversion; A targeted metabolomic approach within the PREDIMED trial

JOSE LOPEZ MIRANDA2026-01-292026-01-29201710.1186/s12986-017-0213-32-s2.0-85028734175https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27501Endocrinology, Diabetes and MetabolismMedicine (miscellaneous)Nutrition and DieteticsSerum metabolites in non-alcoholic fatty-liver disease development or reversion; A targeted metabolomic approach within the PREDIMED trialresearch article